[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363349-105":59,"doc-detail-363349-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ahsp-as-a-novel-non-invasive-urinary-biomarker-for-prostate-cancer","AHSP as a Novel Non-Invasive Urinary Biomarker for Prostate Cancer","","Background Prostate cancer (PCa) remains common in men, and existing tumor markers show limited specificity. Previous work suggested alpha-hemoglobin–stabilizing protein (AHSP) as a promising novel marker. This study evaluated AHSP expression in PCa and examined its clinical relevance using urinary ELISA, immunohistochemistry on 101 PCa tissues, and urinary proteomic profiling to support PCa-specificity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ahsp-as-a-novel-non-invasive-urinary-biomarker-for-prostate-cancer/363349/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ahsp-as-a-novel-non-invasive-urinary-biomarker-for-prostate-cancer/363349.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on AHSP in prostate cancer?","Question",{"text":112,"@type":113},"To investigate AHSP expression in prostate cancer and determine its clinical significance as a non-invasive urinary biomarker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was AHSP measured in the study?",{"text":117,"@type":113},"Urinary AHSP levels were quantified using ELISA, AHSP expression in tissues was assessed by immunohistochemistry, and urinary proteomic profiling was used for comparative validation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does AHSP performance compare with PSA for urinary diagnosis?",{"text":121,"@type":113},"Urinary assays showed that AHSP sensitivity is higher than PSA (96.2% vs. 61.5%), while overall immunohistochemical sensitivity was slightly higher but not statistically significant.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363349,1790779770,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Wang et al. BMC Cancer (2026) 26:574 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15796-8](https://doi.org/10.1186/s12885-026-15796-8)  \nRESEARCH Open Access  \nAHSP as a novel non-invasive urinary biomarker for prostate cancer  \nChen Wang1†, Yang-yang Zhang1†, Hong-qun Wang2,3*, Cong Huang4, Na Yu5, Yan Huang5, Ya-nan Zhu2 and De-lun Yan6  \nAbstract  \nBackground While prostate cancer (PCa) is a common malignant tumor in men, current tumor markers have poor specificity. Our previous exploratory research had identified alpha-hemoglobin–stabilizing protein (AHSP) as a potential novel tumor marker. This study aimed to investigate the expression and clinical significance of AHSP in PCa. Materials and methods AHSP levels in urine samples from patients with PCa, benign prostatic hyperplasia  \n(BPH), urothelial carcinoma, or clear cell renal cell carcinoma (ccRCC) were determined using an enzyme-linked immunosorbent assay (ELISA) . Immunohistochemical staining was performed on 101 PCa tissue samples to assess AHSP expression. Urinary proteomic profiling was employed to compare protein expression patterns in urothelial carcinoma and ccRCC to validate the PCa–specific AHSP expression.  \nResults Immunohistochemical analysis revealed that AHSP was expressed in 93 (92 . 1%) PCa tissue samples. High AHSP expression showed a positive correlation with androgen receptor (AR) level (r = 0 . 353, p \u003C 0. 001) . The incidence of high AHSP expression increased progressively with higher Gleason scores, and there was a significant difference between the Gleason 6–7 and 8–10 groups (57 .4% vs. 83. 0%, p = 0 . 005) . AHSP expression was also positively correlated with Synaptophysin (Syn) expression (r = 0 . 332, p = 0 . 001), and AHSP was observed in normal neural ganglia. While the sensitivity of AHSP was slightly higher than that of prostate-specific antigen (PSA) (92 . 1% vs. 89. 1%), the difference was not statistically significant. Urinary ELISA analysis demonstrated that the PCa group had the highest mean AHSP level (0 . 649 ± 0 . 055ng/ml), which was significantly higher than those in the BPH group (0 .456 ± 0.058 ng/ml), theurothelial carcinoma group (0 .446 ± 0.052 ng/ml), and the ccRCC group (0 .438 ± 0.053 ng/ml) (all p \u003C 0. 0001) . Notably, in urine samples, AHSP demonstrated significantly higher sensitivity than PSA (96 . 2% vs. 61. 5%, p = 0 . 011) .  \nConclusion AHSP expression contributes to the diagnosis of PCa and is associated with tumor differentiation. Its positive correlation with AR expression and neuroendocrine differentiation suggests potential clinical relevance for treatment guidance. In urinary assays, AHSP exhibits higher sensitivity than PSA. AHSP exhibits relatively specific urinary expression in PCa, highlighting its potential as a noninvasive tumor biomarker.  \nKeywords Prostate cancer, Alpha-hemoglobin-stabilizing Protein (AHSP), Androgen receptor, Synaptophysin, Urinary Biomarker, Noninvasive diagnosis  \n†Chen Wang and Yang-yang Zhang are co-first authors.  \n*Correspondence: Hong-qun Wang [whqyy@sina.com](whqyy@sina.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercialNoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended","cbCaikCD38G3M4CL","https://ap.wps.com/l/cbCaikCD38G3M4CL","pdf",2568277,"English","# Abstract\n## Background\n## Materials and methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main goal of the study on AHSP in prostate cancer?\",\"answer\":\"To investigate AHSP expression in prostate cancer and determine its clinical significance as a non-invasive urinary biomarker.\"},{\"question\":\"How was AHSP measured in the study?\",\"answer\":\"Urinary AHSP levels were quantified using ELISA, AHSP expression in tissues was assessed by immunohistochemistry, and urinary proteomic profiling was used for comparative validation.\"},{\"question\":\"How does AHSP performance compare with PSA for urinary diagnosis?\",\"answer\":\"Urinary assays showed that AHSP sensitivity is higher than PSA (96.2% vs. 61.5%), while overall immunohistochemical sensitivity was slightly higher but not statistically significant.\"}]","AHSP as a Novel Non-Invasive Urinary Biomarker for Prostate Cancer | PDF",1790150893,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5be6f23a5fa7bdf49037cf1c56448414.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8486f8653c2dcf9967faad6f5d12b64d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7061bfab89cce404e4c3b812264b616.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddbff529f1a9e9fc0d6b2f419ea32a20.webp",980,1306]